Table 1.
Overview of included studies.
| Reference | Design | Patients | Etiology | tDCS protocol | Sitimulation target | Adverse effect | ||
|---|---|---|---|---|---|---|---|---|
| Martens et al. (8) | Randomized, sham-controlled crossover study | MCS PVS |
29 16 |
TBI Non-TBI |
24 22 |
1 session, 20 minus 4 mA tDCS 1 session, 20 minus sham tDCS 48 hours washout |
Bilateral frontoparietal | None |
| Wu et al. (9) | Randomized, sham-controlled parallel study | MCS PVS |
7 8 |
TBI Non-TBI |
10 5 |
10 session, 20 minus 2 mA tDCS 10 session, 20 minus sham tDCS |
Left/right DLPFC | None |
| Carriere et al. (5) | Randomized, sham-controlled crossover study | MCS | 10 | TBI Non-TBI |
8 2 |
1 session, 20 minus 2 mA tDCS 1 session, 20 minus sham tDCS 48 hours washout |
Left DLPFC | None |
| Martens et al. (19) | Randomized, sham-controlled crossover study | MCS PVS |
21 6 |
TBI Non-TBI |
15 12 |
10 session, 20 minus 2 mA tDCS 10 session, 20 minus sham tDCS 8 weeks washout |
Left DLPFC | Skin redness in 10 patients, Sleppiness in 3 patients, Epileptic seizure in 1 patients |
| Martens et al. (7) | Randomized, sham-controlled crossover study | MCS PVS |
6 4 |
TBI Non-TBI |
5 5 |
1 session, 20 minus 2 mA tDCS 1 session, 20 minus sham tDCS 24 hours washout |
Left/right M1 | None |
| Zhang et al. (10) | Randomized, sham-controlled parallel study | MCS PVS |
15 11 |
TBI Non-TBI |
14 12 |
20 session, 20 minus 2 mA tDCS 20 session, 20 minus sham tDCS |
Left DLPFC | None |
| Estraneo et al. (6) | Randomized, sham-controlled crossover study | MCS PVS |
6 7 |
TBI Non-TBI |
1 12 |
5 session, 20 minus 2 mA tDCS 5 session, 20 minus sham tDCS 1 week washout |
Left DLPFC | None |
| Huang et al. (18) | Randomized, sham-controlled crossover study | MCS | 33 | TBI Non-TBI |
13 20 |
5 session, 20 minus 2 mA tDCS 5 session, 20 minus sham tDCS 5 days washout |
Posterior parietal cortex | None |
Individual patient data were obtained for all trials.
tDCS, transcranial direct current stimulation; MCS, minimally conscious state; PVS, persistent vegetative state; TBI, traumatic brain injury; DLPFC, dorsolateral prefrontal cortex; M1, primary motor cortex.